Taconic Biosciences at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Taconic Biosciences brings 3 presentations to ObesityWeek 2026 in National Harbor. Its sessions show rodent models used to test obesity drugs and to study obesity's effect on cancer therapy. Examples include humanized GLP-1R mice for evaluating orforglipron, diet-induced obese rats treated with cagrilintide, and a colon tumor mouse model in which obesity alters anti-PD-1 response.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Taconic Biosciences Rensselaer, NY | |
Provides genetically engineered, humanized and diet-induced obese rodent models and related services for preclinical research. | Poster Sat Nov 14 7:30pm–8:30pm Cagrilintide Reduces Body Weight and Prevents Adiposity Gain in Diet-Induced Obese Rats Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Humanized GLP-1R Mice Enable Translational Evaluation of Orforglipron With Reduced Energy Intake and Improved Glucose Tolerance Metabolism and integrative physiology Poster Mon Nov 16 2:30pm–3:30pm Obesity Alters Anti–PD-1 Tumor Response and Metabolic Signatures in a Syngeneic Colon Mouse Model Chronic disease and obesity complications |
Find decision makers at Taconic Biosciences
Tell us what you sell and we’ll find the people at Taconic Biosciences most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction